Menu

THE JORDANIAN PHARMACEUTICAL MANUFACTURING Financial

Trading Information in the Regular Market

2020 2019 2018
Par Value/Share (JD) 1.00 1.00 1.00
Closing Price (JD) 0.24 0.27 0.49
Value Traded (JD) 428,709 225,687 583,845
No. of Shares Traded 1,398,780 632,989 1,527,080
No. of Transactions 855 656 1,520
No. of Subscribed Shares 25,312,500 25,312,500 25,312,500
Market Capitalization (JD) 6,075,000 6,834,375 12,403,125
Fiscal Year Ended 31/12/2020 31/12/2019 31/12/2018

Assets (JD)

2020 2019 2018
Cash on Hand & at Banks 208,409 450,693 238,473
Notes Receivable 0 0 0
Short Term Investments 0 0 0
Inventory 6,104,847 5,773,312 5,040,464
Spare Parts 0 0 0
Total Current Assets 23,683,990 21,763,400 27,428,765
Long Term Investments 3,268,061 3,152,726 4,093,265
Fixed Assets, Net 3,058,720 3,304,350 3,316,875
Lands 490,127 490,127 490,127
Projects in Progress 0 0 0
Total Fixed Assets 3,548,847 3,794,477 3,807,002
Other Assets 9,753,136 9,974,851 10,240,839
Total Assets 40,254,034 38,685,454 45,569,871

Liabilities (JD)

2020 2019 2018
Credit Banks 955,811 949,830 707,156
Short Term Loans 0 0 7,261,346
Accrued Part of Long Term Loans 6,308,732 1,646,897 0
Total Current Liabilities 24,099,213 15,308,346 20,079,503
Long Term Loans & Notes Payable 17,554,740 12,554,500 5,067,524
Corporate Bonds 0 0 0
Other Liabilities 8,717,110 9,220,667 11,481,991
Total Liabilities 50,371,063 37,083,513 36,629,018

Shareholders Equity (JD)

2020 2019 2018
Authorized Capital 25,312,500 25,312,500 25,312,500
Subscribed Capital 25,312,500 25,312,500 25,312,500
Paid in Capital 25,312,500 25,312,500 25,312,500
Compulsory Reserves 2,059,193 2,059,193 2,059,193
Voluntary Reserve 0 0 0
Other Reserves -66,637 -69,959 0
Issuance Premium 0 0 0
Issuance Discount 0 0 0
Treasury Stocks 0 0 0
Cash Dividends 0 0 0
Stock Dividends 0 0 0
Accumulated Change in Fair Value -2,323,510 -2,284,746 -930,000
Retained Earnings -35,233,768 -23,596,782 -17,737,444
Total Shareholders Equity -10,252,222 1,420,206 8,704,249
Non-controlling Interest 135,193 181,735 236,604
Total Liabilities & Shareholders Equity 40,254,034 38,685,454 45,569,871

Income Statement (JD)

2020 2019 2018
Operating Revenues 14,414,141 9,977,197 22,205,163
Operating Expenses 9,311,891 7,076,480 12,445,255
Gross Profit 5,102,250 2,900,717 9,759,908
General and Administrative Expenses 2,995,806 2,320,621 2,527,565
Selling and Distribution Expenses 4,092,784 5,285,945 5,434,794
Depreciation (Period) 713,329 740,631 643,028
Other Operating Expenses 970,419 1,918,111 4,100,900
Net Operating Income -2,956,759 -6,623,960 -2,303,351
Other Revenues 657,838 2,033,120 135,305
Other Expenses 5,804,181 169,061 93,956
Income Before Interest & Tax -8,103,102 -4,759,901 -2,262,002
Interest Expenses 1,476,031 1,147,462 1,800,182
Net Income Before Tax -9,579,133 -5,907,363 -4,062,184
Income Tax (Period) 2,104,406 6,563 51,293
Income Tax (Previous Years) 0 0 0
Universities and Research Train Fees 0 0 0
Board of Directors Remuniration 0 0 0
Net Income -11,683,539 -5,913,926 -4,113,477
Non-controlling Interest -46,553 -54,588 -17,437
Net Income Pertains to Shareholders -11,636,986 -5,859,338 -4,096,040

Cash Flow (JD)

2020 2019 2018
Cash Balance (Beginning) -499,137 -468,683 516,277
Net Cash Flow from (Used in) Operating Activities -9,470,214 -443,740 -1,863,269
Net Cash Flow from (Used in) Investing Activities -246,639 -17,386 -565,111
Net Cash Flow from (Used in) Financing Activities 9,468,588 430,672 1,443,420
Cash Balance (Ending) -747,402 -499,137 -468,683

Financial Ratios

2020 2019 2018
Turnover Ratio % 5.526 2.501 6.033
Earning Per Share (JD) -0.460 -0.232 -0.162
Dividend Per Share (JD) 0.000 0.000 0.000
Book Value Per Share (JD) -0.405 0.056 0.344
Price Earnings Ratio (Times) -0.522 -1.166 -3.028
Dividend Yield % 0.000 0.000 0.000
Dividend Per Share to Earning Per Share % 0.000 0.000 0.000
Price to Book Value (Times) -0.593 4.812 1.425
Gross Margin % 35.398 29.074 43.953
Margin Before Interest and Tax % -56.216 -47.708 -10.187
Profit Margin % -81.056 -59.274 -18.525
Return On Assets % -29.025 -15.287 -9.027
Return On Equity % 113.507 -412.570 -47.058
Debt Ratio % 125.133 95.859 80.380
Equity Ratio % -25.133 4.141 19.620
Interest Coverage Ratio (Times) -5.490 -4.148 -1.257
Total Assets Turnover (Times) 0.358 0.258 0.487
Fixed Assets Turnover (Times) 4.062 2.629 5.833
Working Capital Turnover (Times) -34.714 1.546 3.021
Current Ratio (Times) 0.983 1.422 1.366
Working Capital (JD) -415,223.000 6,455,054.000 7,349,262.000